Antibacterial activities of hexadecanoic acid methyl ester and green-synthesized silver nanoparticles against multidrug-resistant bacteria

被引:122
作者
Shaaban, Mohamed T. [1 ]
Ghaly, Mohamed F. [2 ]
Fahmi, Sara M. [1 ]
机构
[1] Menoufia Univ, Fac Sci, Dept Bot & Microbiol, Menoufia, Egypt
[2] Zagazig Univ, Dept Bot & Microbiol, Fac Sci, Zagazig, Egypt
关键词
antibacterial activities; hexadecanoic acid methyl ester; multidrug‐ resistant bacteria; silver nanoparticles; ANTIMICROBIAL ACTIVITY; ANTIBIOTICS;
D O I
10.1002/jobm.202100061
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Antibacterial drug resistance is considered one of the biggest threats to human health worldwide, and the overuse of antibiotics accelerates this problem. Multidrug-resistant (MDR) bacteria are becoming harder to treat as the antibiotics used to treat them become less effective. Therefore, it is necessary to evaluate novel methods to control MDR bacteria. In this study, 40 bacterial isolates were collected from diabetic patients. The sensitivity of 40 bacterial isolates to seven antibiotics was evaluated. Four bacterial isolates were resistant to all antibiotic groups. The MDR pathogenic bacteria were selected and identified morphologically and biochemically and confirmed by VITEK (R) 2 system as follows: Staphylococcus aureus W35, Pseudomonas aeruginosa D31, Klebsiella pneumoniae DF30, and K. pneumoniae B40. Identification of the most resistant P. aeruginosa D31 was confirmed by the sequencing of a 16S ribosomal RNA gene with an accession number (MW241596). The inhibitory activity of eight types of native grown plant extracts against MDR bacteria was studied. Clove alcoholic extract (CAE) showed the highest inhibitory activity against MDR bacteria. Gas chromatography-mass spectrometry analysis of partially purified CAE at 0.9 Rf detected by thin-layer chromatography showed an active compound named hexadecenoic acid methyl ester with the highest antimicrobial effect against clinical pathogenic bacteria. The formation of silver nanoparticles (AgNPs) by CAE was studied. Evaluation of AgNPs was investigated by X-ray diffraction, UV-Vis, and transmission electron microscopy. The antibacterial effect of AgNPs after 2, 4, and 6 days in light and dark conditions was evaluated. Finally, the AgNPs synthesized using CAE possess good inhibition activity against the tested pathogenic bacteria. As a result, the bactericidal components listed above were promising in reducing MDR bacteria and can be used for treatments of bacterial infection and in the development of safe products with a natural base.
引用
收藏
页码:557 / 568
页数:12
相关论文
共 37 条
  • [1] Characterization and identification of multidrug resistant bacteria from some egyptian patients
    [J]. Abdel-Shafi, Seham, 1600, Asian Network for Scientific Information (12): : 65 - 73
  • [2] Biomimetic synthesis of silver nanoparticles using Syzygium aromaticum (clove) extract: Catalytic and antimicrobial effects
    Ajitha, B.
    Reddy, Y. Ashok Kumar
    Lee, Yonghee
    Kim, Min Jun
    Ahn, Chi Won
    [J]. APPLIED ORGANOMETALLIC CHEMISTRY, 2019, 33 (05)
  • [3] Allahverdiyev AM, 2011, EXPERT REV ANTI-INFE, V9, P1035, DOI [10.1586/ERI.11.121, 10.1586/eri.11.121]
  • [4] Anneken D.J., 2000, Ullmann's Encyclopedia of Industrial Chemistry
  • [5] Antibacterial, anticoagulant and cytotoxic evaluation of biocompatible nanocomposite of chitosan loaded green synthesized bioinspired silver
    Asghar, Muhammad Arif
    Yousuf, Rabia Ismail
    Shoaib, Muhammad Harris
    Asghar, Muhammad Asif
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2020, 160 : 934 - 943
  • [6] Bassetti Matteo, 2018, Drugs Context, V7, P212527, DOI 10.7573/dic.212527
  • [7] BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
  • [8] Antimicrobial Resistance and the Alternative Resources with Special Emphasis on Plant-Based Antimicrobials-A Review
    Chandra, Harish
    Bishnoi, Parul
    Yadav, Archana
    Patni, Babita
    Mishra, Abhay Prakash
    Nautiyal, Anant Ram
    [J]. PLANTS-BASEL, 2017, 6 (02): : 457 - 462
  • [9] Cho, 2019, COLLOID SURFACE, V73, P332
  • [10] Clinical and Laboratory Standards Institute, 2019, M100 Performance Standars for Antimicrobial Susceptibility Testing